Advanced Enzyme Technologies Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Advanced Enzyme Technologies heeft een totaal eigen vermogen van ₹13.9B en een totale schuld van ₹256.9M, wat de schuld-eigenvermogensverhouding op 1.8% brengt. De totale activa en totale passiva bedragen respectievelijk ₹15.5B en ₹1.6B. De EBIT Advanced Enzyme Technologies is ₹1.7B waardoor de rentedekking -16.8 is. Het heeft contanten en kortetermijnbeleggingen van ₹5.1B.
Belangrijke informatie
1.8%
Verhouding schuld/eigen vermogen
₹256.89m
Schuld
| Rente dekkingsratio | -16.8x |
| Contant | ₹5.07b |
| Aandelen | ₹13.89b |
| Totaal verplichtingen | ₹1.60b |
| Totaal activa | ₹15.49b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹8.1B ) ADVENZYMES } overtreffen de korte termijn passiva ( ₹1.0B ).
Langlopende schulden: De kortetermijnactiva ADVENZYMES ( ₹8.1B ) overtreffen de langetermijnschulden ( ₹564.4M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ADVENZYMES heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van ADVENZYMES is de afgelopen 5 jaar gedaald van 2.5% naar 1.8%.
Schuldendekking: De schuld van ADVENZYMES wordt goed gedekt door de operationele kasstroom ( 553.6% ).
Rentedekking: ADVENZYMES verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.